Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

EGRX Stock Annual Cash Flow. Download in Excel

Eagle Pharmaceuticals Inc. logo

Eagle Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Drug Manufacturers - Specialty & Generic

0.55
 
USD
  
-0.05
  
(-8.33%)
Previous close: 0.6  Open: 0.01  Bid:   Ask:
52 week range    
0.00   
   6.81
Mkt Cap: 8 M  Avg Vol (90 Days): 164,273
Peers   
JNJ / 
GSK / 
NVS / 
TEVA / 
AMGN / 
LLY / 
Last updated: Monday 23rd December 2024

Stock Rankings

41
MarketXLS Rank
80
Value
15
Technical
28
Quality
How are these ranks calculated?
Search for a stock

Financials

EGRX Cash Flow

Annual
Invalid dateSep-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
(Increase) Decrease in inventories-1 M-14 M12 M-2 M-6 M2 M-2 M-14 M-8 M
(Increase) Decrease in other current assets1000.0-98000.0-7000.0-570000.0
(Increase) Decrease in other current liabilities-3 M-520000.0-6 M
(Increase) Decrease in other working capital-599000.0-2 M-1 M-19 M
(Increase) Decrease in payables3 M356000.011 M-8 M4 M-4 M806000.010 M3 M
(Increase) Decrease in receivables-2 M-14 M-16 M-12 M-13 M18 M-3 M10 M-31 M
Acquisitions-32 M-17 M-87 M
Amortization of intangibles948000.03 M3 M3 M3 M3 M11 M
AssetImpairmentCharge7 M3 M
CapitalExpenditureReported46000.02 M16 M5 M133000.0777000.0747000.0323000.0178000.0
Cash at beginning of period10 M35 M79 M53 M115 M79 M110 M103 M98 M
Cash at end of period23 M79 M53 M115 M79 M110 M103 M98 M55 M
Cash flow-14 M-10 M52 M66 M53 M56 M50 M28 M51 M
CashFlowFromContinuingInvestingActivities-20 M-2 M-45 M-13 M-896000.0-777000.0-18 M-5 M-87 M
ChangeInAccountPayable3 M356000.011 M-8 M-2 M-4 M806000.010 M3 M
ChangeInAccruedExpense7 M12 M-316000.0-9 M8 M4 M-4 M8 M44 M
ChangeInInterestPayable7 M12 M-316000.0-9 M8 M
ChangeInPayablesAndAccruedExpense10 M12 M10 M-18 M12 M-388000.0-4 M18 M47 M
ChangeInWorkingCapital3 M-16 M736000.0-32 M-7 M19 M-11 M12 M-11 M
ChangesInAccountReceivables-2 M-14 M-16 M-12 M-13 M18 M-3 M10 M-31 M
CommonStockPayments-37 M-44 M-73 M-18 M-35 M-21 M-18 M
Current deferred income taxes-30 M17 M-2 M152000.0-2 M-4 M-8 M
Deferred income taxes-30 M17 M-2 M152000.0-2 M-4 M-8 M
Depreciation104000.0112000.0641000.0932000.01 M972000.0872000.0764000.0646000.0
Depreciation unreconciled104000.0112000.02 M4 M4 M5 M5 M5 M14 M
DepreciationAndAmortization104000.0112000.02 M4 M4 M5 M4 M4 M12 M
FinancingCashFlow46 M56 M-34 M8 M-88 M-24 M-38 M-28 M-6 M
Free cash flow-14 M-12 M38 M61 M53 M55 M49 M28 M51 M
GainLossOnInvestmentSecurities-686000.0962000.0
GainLossOnSaleOfPPE273000.0-2 M
IncomeTaxPaidSupplementalData482000.03 M11 M2 M7 M6 M10 M28 M
InterestPaidSupplementalData-8000.011000.08000.0651000.02 M2 M2 M1 M2 M
Issuance of capital stock46 M54 M
Issuance of debt-110 M-15 M
IssuanceOfCapitalStock46 M54 M
IssuanceOfDebt49 M-4 M-6 M-5 M-8 M11 M
Net cash from financing activities46 M56 M-34 M8 M-88 M-24 M-38 M-28 M-6 M
Net cash from investing activities-20 M-2 M-45 M-13 M-896000.0-777000.0-18 M-5 M-87 M
Net cash from operating activities-14 M-10 M52 M66 M53 M56 M49 M28 M51 M
Net change in cash & cash equivalents12 M44 M-26 M62 M-36 M31 M-7 M-5 M-42 M
Net income from continuing operations-18 M3 M81 M52 M32 M14 M12 M-9 M36 M
NetBusinessPurchaseAndSale-32 M-17 M-87 M
NetCommonStockIssuance46 M54 M-37 M-44 M-73 M-18 M-35 M-21 M-18 M
NetIntangiblesPurchaseAndSale-14 M-750000.0-17 M-5 M
NetInvestmentPropertiesPurchaseAndSale-20 M957000.0-7 M-763000.0-5 M
NetInvestmentPurchaseAndSale-20 M957000.0-7 M-763000.0-5 M
NetIssuancePaymentsOfDebt49 M-4 M-6 M-5 M-8 M11 M
NetLongTermDebtIssuance49 M-4 M-6 M105 M-8 M26 M
NetPPEPurchaseAndSale-46000.0-2 M160000.0-4 M-133000.0-777000.0-747000.0-323000.0-178000.0
Operating (gains) losses273000.0-2 M-686000.05 M
Other financing charges net-1000.0-286000.0-20 M-198000.0-2 M-2 M-1 M
Other investing changes net957000.0-7 M-763000.0
Other non-cash items1 M4 M338000.025 M27 M17 M44 M24 M16 M
ProceedsFromIssuanceOfWarrants21000.0
ProceedsFromStockOptionExercised65000.01 M4 M4 M9 M260000.04 M2 M2 M
Purchase of Float term investments-20 M-106 M-62 M-5 M
Purchase of property plant & equipment-46000.0-2 M-14 M-5 M-133000.0-777000.0-747000.0-323000.0-178000.0
Purchase of short term investments50 M110 M80 M
PurchaseOfIntangibles-14 M-750000.0-17 M-5 M
PurchaseOfInvestment-20 M-106 M-62 M-5 M
PurchaseOfPPE-46000.0-2 M-2 M-4 M-133000.0-777000.0-747000.0-323000.0-178000.0
Repayment of debt-1 M-4 M-6 M-5 M-8 M-54 M
RepaymentOfDebt-1 M-4 M-6 M-115 M-8 M-69 M
Repurchase of capital stock-37 M-44 M-73 M-18 M-35 M-21 M-18 M
Revenue per share948000.03 M3 M4 M4 M5 M13 M
Sale of short term investments-20 M106 M62 M
SaleOfInvestment-20 M106 M62 M
SaleOfPPE2 M
ShortTermDebtPayments-110 M-15 M
StockBasedCompensation606000.04 M10 M15 M19 M22 M25 M20 M16 M
UnrealizedGainLossOnInvestmentSecurities5 M6 M4 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University